Marie E. Fallon - Jan 24, 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role: Chief Accounting Officer
Signature: /s/ Karen Tepichin, Attorney-in-fact
Stock symbol: DNA
Transactions as of: Jan 24, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/26/2022, 05:42 PM
Previous filing: Oct 7, 2022
Next filing: Mar 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNA	Restricted Stock Units	Award	$0	+40K		$0.00	40K	Jan 24, 2022	Class B Common Stock	40K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock.
F2	The RSUs vest as follows: 5% of the underlying shares on January 1, 2023; 12 monthly installments of 0.83% of the underlying shares thereafter; 12 monthly installments of 1.25% of the underlying shares thereafter; 24 monthly installments of 1.67% of the underlying shares thereafter; and 12 monthly installments of 2.5% of the underlying shares thereafter.

Remarks:

Chief Accounting Officer